Summary: Blockade of the SUMO pathway inhibits tumorigenesis through two different mechanisms: (i) stimulation of autophagy-mediated cancer cell death via TRIB3 upregulation; and (ii) inhibition of invasiveness via abrogation of RAC1 SUMOylation. This evidence concerns the gene RAC1 and cancer.